Pour une meilleure utilisation, nous vous conseillons d’activer Javascript dans votre navigateur.

VEGFR2/CD309 anticorps (AA 252-301)

Name: VEGFR2/CD309 anticorps (AA 252-301)
SKU: ABIN6744376
Price: 823.83 EUR
Availability: InStock

VEGFR2 Reactivité: Humain, Porc, Chien, Singe, Boeuf (Vache), Cheval WB Hôte: Lapin Polyclonal unconjugated

Image no. 1 for anti-VEGF Receptor 2 (VEGFR2) (AA 252-301) antibody (ABIN6744376) (VEGFR2/CD309 anticorps (AA 252-301))

1 image

N° du produit ABIN6744376

Fiche de données

Antigène Voir toutes VEGFR2/CD309 (VEGFR2) Anticorps

VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
Épitope
36

34

27

21

20

16

16

13

13

10

9

8

8

6

6

6

5

4

4

3

3

2

2

2

2

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
AA 252-301
Reactivité
292

185

136

17

8

3

3

2

2

2

1

1

1

1

1

1

1

1

1

1
Humain, Porc, Chien, Singe, Boeuf (Vache), Cheval
Hôte
280

54

18

2

1

1
Lapin
Anticorps secondaires appropriés
Clonalité
275

81
Polyclonal
Conjugué
150

32

20

14

13

13

12

12

11

11

11

11

6

6

6

6

6

3

2

2

2

1

1

1

1

1

1

1
Cet anticorp VEGFR2/CD309 est non-conjugé
Application
213

127

91

87

56

27

26

21

19

14

13

12

9

7

7

4

3

2

2

2

2

1

1

1

1
Western Blotting (WB)

Specificité

Human KDR / VEGFR2

Homologie

Percent identity by BLAST analysis: Human, Dog, Horse, Pig (100%) Bovine (86%).

Purification

Immunoaffinity purified

Immunogène

Synthetic peptide located between aa252-301 of human KDR (P35968, NP_002244). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Marmoset, Dog, Horse, Pig (100%), Bovine, Bat (86%), Platypus (83%).

Type of Immunogen: Synthetic peptide

Top Product

Discover our top product VEGFR2 Anticorps primaire
anti-VEGF Receptor 2 (VEGFR2) (AA 20-200) antibody
VEGFR2 Reactivité: Humain WB, IHC Hôte: Lapin Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 1326-1356), (C-Term) antibody
VEGFR2 Reactivité: Humain WB, IF, FACS, IHC (p) Hôte: Lapin Polyclonal RB01536 unconjugated

anti-VEGF Receptor 2 (VEGFR2) (pTyr951) antibody
VEGFR2 Reactivité: Humain, Souris, Rat WB, IHC, ELISA, IF, ICC Hôte: Lapin Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 20-242) antibody
VEGFR2 Reactivité: Humain WB, IHC (p) Hôte: Lapin Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 1326-1356) antibody
VEGFR2 Reactivité: Humain WB, IHC, ELISA, IF, FACS Hôte: Lapin Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 101-200) antibody
VEGFR2 Reactivité: Humain, Souris, Rat, Lapin ELISA, FACS, IHC (p), IF (p), IHC (fro) Hôte: Lapin Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 20-764) antibody
VEGFR2 Reactivité: Humain WB, ELISA, FACS, ICC Hôte: Souris Monoclonal 4B4 unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 1225-1356) antibody
VEGFR2 Reactivité: Humain WB, IHC, ELISA, FACS, ICC, Neut Hôte: Souris Monoclonal 1A9A3 unconjugated

anti-VEGF Receptor 2 (VEGFR2) (pTyr1214) antibody
VEGFR2 Reactivité: Humain, Souris, Rat WB, IHC, ELISA, IF, ICC Hôte: Lapin Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 454-469), (Middle Region) antibody
VEGFR2 Reactivité: Humain WB, IHC (p), ICC, IHC (fro) Hôte: Lapin Polyclonal unconjugated

Indications d'application

Approved: WB (0.2 - 1 μg/mL)

Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody.

Commentaires

Target Species of Antibody: Human

Restrictions

For Research Use only
Format

Lyophilized

Reconstitution

Distilled water

Concentration

Lot specific

Buffer

Lyophilized

Conseil sur la manipulation

Avoid repeat freeze-thaw cycles.

Stock

4 °C,-20 °C

Stockage commentaire

Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
Antigène

VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Autre désignation

KDR / VEGFR2 (VEGFR2 Produits)

Synonymes

anticorps CD309, anticorps FLK1, anticorps VEGFR, anticorps VEGFR2, anticorps 6130401C07, anticorps Flk-1, anticorps Flk1, anticorps Krd-1, anticorps Ly73, anticorps VEGFR-2, anticorps sVEGFR-2, anticorps Vegfr-2, anticorps FLK-1, anticorps flk-1, anticorps vegfr-2, anticorps KDR, anticorps FLK/KDR, anticorps flk1, anticorps flk1b, anticorps kdrb, anticorps si:busm1-205d10.1, anticorps si:ch211-254j6.1, anticorps si:ch211-278f21.4, anticorps wu:fc31a09, anticorps fk52c05, anticorps flk, anticorps kdr, anticorps kdra, anticorps vegfr2, anticorps vegfr4, anticorps vegr2, anticorps wu:fk52c05, anticorps kinase insert domain receptor, anticorps kinase insert domain protein receptor, anticorps vascular endothelial growth factor receptor kdr-like, anticorps kinase insert domain receptor (a type III receptor tyrosine kinase), anticorps kinase insert domain receptor like, anticorps KDR, anticorps Kdr, anticorps LOC100136647, anticorps kdr, anticorps kdrl

Sujet

Name/Gene ID: KDR
Subfamily: VEGF Receptor
Family: Protein Kinase

Synonyms: KDR, CD309, Fetal liver kinase 1, Fetal liver kinase-1, FLK-1, FLK1, Kinase insert domain receptor, Quek1, VEGFR, VEGFR2, Soluble VEGFR2, VEGF receptor 2, VEGFR-2, CD309 antigen, VEGF-R2

ID gène

3791

NCBI Accession

NP_002244

UniProt

P35968

Pathways

Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling